176 related articles for article (PubMed ID: 9016869)
1. Peripheral expression of Jak3 is required to maintain T lymphocyte function.
Thomis DC; Berg LJ
J Exp Med; 1997 Jan; 185(2):197-206. PubMed ID: 9016869
[TBL] [Abstract][Full Text] [Related]
2. T cells from Jak3-deficient mice have intact TCR signaling, but increased apoptosis.
Thomis DC; Lee W; Berg LJ
J Immunol; 1997 Nov; 159(10):4708-19. PubMed ID: 9366394
[TBL] [Abstract][Full Text] [Related]
3. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3.
Thomis DC; Gurniak CB; Tivol E; Sharpe AH; Berg LJ
Science; 1995 Nov; 270(5237):794-7. PubMed ID: 7481767
[TBL] [Abstract][Full Text] [Related]
4. Requirement for Jak3 in mature T cells: its role in regulation of T cell homeostasis.
Sohn SJ; Forbush KA; Nguyen N; Witthuhn B; Nosaka T; Ihle JN; Perlmutter RM
J Immunol; 1998 Mar; 160(5):2130-8. PubMed ID: 9498750
[TBL] [Abstract][Full Text] [Related]
5. T cell development and activation in Jak3-deficient mice.
Baird AM; Thomis DC; Berg LJ
J Leukoc Biol; 1998 Jun; 63(6):669-77. PubMed ID: 9620658
[TBL] [Abstract][Full Text] [Related]
6. Janus kinase 3 (Jak3) is essential for common cytokine receptor gamma chain (gamma(c))-dependent signaling: comparative analysis of gamma(c), Jak3, and gamma(c) and Jak3 double-deficient mice.
Suzuki K; Nakajima H; Saito Y; Saito T; Leonard WJ; Iwamoto I
Int Immunol; 2000 Feb; 12(2):123-32. PubMed ID: 10653847
[TBL] [Abstract][Full Text] [Related]
7. Janus kinase 3-deficient T lymphocytes have an intrinsic defect in CCR7-mediated homing to peripheral lymphoid organs.
García-Zepeda EA; Licona-Limón I; Jiménez-Sólomon MF; Soldevila G
Immunology; 2007 Oct; 122(2):247-60. PubMed ID: 17521370
[TBL] [Abstract][Full Text] [Related]
8. Crucial role of Jak3 in negative selection of self-reactive T cells.
Saijo K; Park SY; Ishida Y; Arase H; Saito T
J Exp Med; 1997 Jan; 185(2):351-6. PubMed ID: 9016883
[TBL] [Abstract][Full Text] [Related]
9. Defective lymphoid development in mice lacking Jak3.
Nosaka T; van Deursen JM; Tripp RA; Thierfelder WE; Witthuhn BA; McMickle AP; Doherty PC; Grosveld GC; Ihle JN
Science; 1995 Nov; 270(5237):800-2. PubMed ID: 7481769
[TBL] [Abstract][Full Text] [Related]
10. Requirement for an initial signal from the membrane-proximal region of the interleukin 2 receptor gamma(c) chain for Janus kinase activation leading to T cell proliferation.
Nelson BH; McIntosh BC; Rosencrans LL; Greenberg PD
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1878-83. PubMed ID: 9050873
[TBL] [Abstract][Full Text] [Related]
11. The Jak family tyrosine kinase Jak3 is required for IL-2 synthesis by naive/resting CD4+ T cells.
Thomis DC; Aramburu J; Berg LJ
J Immunol; 1999 Nov; 163(10):5411-7. PubMed ID: 10553066
[TBL] [Abstract][Full Text] [Related]
12. Development of autologous, oligoclonal, poorly functioning T lymphocytes in a patient with autosomal recessive severe combined immunodeficiency caused by defects of the Jak3 tyrosine kinase.
Brugnoni D; Notarangelo LD; Sottini A; Airò P; Pennacchio M; Mazzolari E; Signorini S; Candotti F; Villa A; Mella P; Vezzoni P; Cattaneo R; Ugazio AG; Imberti L
Blood; 1998 Feb; 91(3):949-55. PubMed ID: 9446656
[TBL] [Abstract][Full Text] [Related]
13. Cytokine-independent Jak3 activation upon T cell receptor (TCR) stimulation through direct association of Jak3 and the TCR complex.
Tomita K; Saijo K; Yamasaki S; Iida T; Nakatsu F; Arase H; Ohno H; Shirasawa T; Kuriyama T; O'Shea JJ; Saito T
J Biol Chem; 2001 Jul; 276(27):25378-85. PubMed ID: 11349123
[TBL] [Abstract][Full Text] [Related]
14. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice.
Park SY; Saijo K; Takahashi T; Osawa M; Arase H; Hirayama N; Miyake K; Nakauchi H; Shirasawa T; Saito T
Immunity; 1995 Dec; 3(6):771-82. PubMed ID: 8777722
[TBL] [Abstract][Full Text] [Related]
15. Jak3 selectively regulates Bax and Bcl-2 expression to promote T-cell development.
Wen R; Wang D; McKay C; Bunting KD; Marine JC; Vanin EF; Zambetti GP; Korsmeyer SJ; Ihle JN; Cleveland JL
Mol Cell Biol; 2001 Jan; 21(2):678-89. PubMed ID: 11134353
[TBL] [Abstract][Full Text] [Related]
16. Distinct effects of Jak3 signaling on alphabeta and gammadelta thymocyte development.
Eynon EE; Livák F; Kuida K; Schatz DG; Flavell RA
J Immunol; 1999 Feb; 162(3):1448-59. PubMed ID: 9973401
[TBL] [Abstract][Full Text] [Related]
17. Cutting edge: an alternative pathway of CD4+ T cell differentiation is induced following activation in the absence of gamma-chain-dependent cytokine signals.
Mayack SR; Berg LJ
J Immunol; 2006 Feb; 176(4):2059-63. PubMed ID: 16455959
[TBL] [Abstract][Full Text] [Related]
18. Unexpected and variable phenotypes in a family with JAK3 deficiency.
Frucht DM; Gadina M; Jagadeesh GJ; Aksentijevich I; Takada K; Bleesing JJ; Nelson J; Muul LM; Perham G; Morgan G; Gerritsen EJ; Schumacher RF; Mella P; Veys PA; Fleisher TA; Kaminski ER; Notarangelo LD; O'Shea JJ; Candotti F
Genes Immun; 2001 Dec; 2(8):422-32. PubMed ID: 11781709
[TBL] [Abstract][Full Text] [Related]
19. Jak3 activation in human lymphocyte precursor cells.
Sharfe N; Dadi HK; O'Shea JJ; Roifman CM
Clin Exp Immunol; 1997 Jun; 108(3):552-6. PubMed ID: 9182906
[TBL] [Abstract][Full Text] [Related]
20. Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: role of soluble products from human renal cell carcinomas.
Kolenko V; Wang Q; Riedy MC; O'Shea J; Ritz J; Cathcart MK; Rayman P; Tubbs R; Edinger M; Novick A; Bukowski R; Finke J
J Immunol; 1997 Sep; 159(6):3057-67. PubMed ID: 9300731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
